UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Upgrade of Chrysomycin A as a novel Topoisomerase II inhibitor to Curb KRAS-mutant lung adenocarcinoma progression. Journal article
Zhang JunMin, Liu Pei, Chen JianWei, Yao DaHong, Liu Qing, Zhang JuanHong, Zhang HuaWei, Leung Elaine Lai Han, Yao XiaoJun, Liu Liang. Upgrade of Chrysomycin A as a novel Topoisomerase II inhibitor to Curb KRAS-mutant lung adenocarcinoma progression.[J]. Pharmacological Research, 2023.
Authors:  Zhang JunMin;  Liu Pei;  Chen JianWei;  Yao DaHong;  Liu Qing; et al.
Adobe PDF | Favorite |   IF:9.1/9.0 | Submit date:2023/10/23
Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression Journal article
Zhang JunMin, Liu Pei, Chen JianWei, Yao DaHong, Liu Qing, Zhang JuanHong, Zhang Hua Wei, Leung Elaine Lai Han, Yao XiaoJun, Liu Liang. Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression[J]. Pharmacological Research, 2023, 187.
Authors:  Zhang JunMin;  Liu Pei;  Chen JianWei;  Yao DaHong;  Liu Qing; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:9.1/9.0 | Submit date:2023/02/08
Apoptosis  Chrysomycin a  Dna Damage  Reactive Oxygen Species  Topoisomerase Ii Activity